Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
Enolase 1 (ENO1) is an oxidative stress protein expressed in endothelial cells. This study aimed to investigate the correlation of ENO1 with prognosis, tumor stage, and levels of tumor-infiltrating immune cells in multiple cancers. ENO1 expression and its influence on tumor stage and clinical progno...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.593706/full |
_version_ | 1818915132234792960 |
---|---|
author | Wenhua Xu Wenna Yang Chunfeng Wu Xiaocong Ma Haoyu Li Jinghui Zheng |
author_facet | Wenhua Xu Wenna Yang Chunfeng Wu Xiaocong Ma Haoyu Li Jinghui Zheng |
author_sort | Wenhua Xu |
collection | DOAJ |
description | Enolase 1 (ENO1) is an oxidative stress protein expressed in endothelial cells. This study aimed to investigate the correlation of ENO1 with prognosis, tumor stage, and levels of tumor-infiltrating immune cells in multiple cancers. ENO1 expression and its influence on tumor stage and clinical prognosis were analyzed by UCSC Xena browser, Gene Expression Profiling Interactive Analysis (GEPIA), The Cancer Genome Atlas (TCGA), and GTEx Portal. The ENO1 mutation analysis was performed by cBio Portal, and demonstrated ENO1 mutation (1.8%) did not impact on tumor prognosis. The relationship between ENO1 expression and tumor immunity was analyzed by Tumor Immune Estimation Resource (TIMER) and GEPIA. The potential functions of ENO1 in pathways were investigated by Gene Set Enrichment Analysis. ENO1 expression was significantly different in tumor and corresponding normal tissues. ENO1 expression in multiple tumor tissues correlated with prognosis and stage. ENO1 showed correlation with immune infiltrates including B cells, CD8+ and CD4+ T cells, macrophages, neutrophils, and dendritic cells, and tumor purity. ENO1 was proved to be involved in DNA replication, cell cycle, apoptosis, glycolysis process, and other processes. These findings indicate that ENO1 is a potential prognostic biomarker that correlates with cancer progression immune infiltration. |
first_indexed | 2024-12-19T23:57:25Z |
format | Article |
id | doaj.art-a21db29e1317419b9ba8c1402a137fdd |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-12-19T23:57:25Z |
publishDate | 2021-02-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-a21db29e1317419b9ba8c1402a137fdd2022-12-21T20:00:57ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.593706593706Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer AnalysisWenhua Xu0Wenna Yang1Chunfeng Wu2Xiaocong Ma3Haoyu Li4Jinghui Zheng5Department of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaDepartment of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaDepartment of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaGraduate School, Guangxi University of Chinese Medicine, Nanning City, ChinaDepartment of Ophthalmology, Jingliang Eye Hospital Affiliated to Guangxi Medical University, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, ChinaDepartment of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaEnolase 1 (ENO1) is an oxidative stress protein expressed in endothelial cells. This study aimed to investigate the correlation of ENO1 with prognosis, tumor stage, and levels of tumor-infiltrating immune cells in multiple cancers. ENO1 expression and its influence on tumor stage and clinical prognosis were analyzed by UCSC Xena browser, Gene Expression Profiling Interactive Analysis (GEPIA), The Cancer Genome Atlas (TCGA), and GTEx Portal. The ENO1 mutation analysis was performed by cBio Portal, and demonstrated ENO1 mutation (1.8%) did not impact on tumor prognosis. The relationship between ENO1 expression and tumor immunity was analyzed by Tumor Immune Estimation Resource (TIMER) and GEPIA. The potential functions of ENO1 in pathways were investigated by Gene Set Enrichment Analysis. ENO1 expression was significantly different in tumor and corresponding normal tissues. ENO1 expression in multiple tumor tissues correlated with prognosis and stage. ENO1 showed correlation with immune infiltrates including B cells, CD8+ and CD4+ T cells, macrophages, neutrophils, and dendritic cells, and tumor purity. ENO1 was proved to be involved in DNA replication, cell cycle, apoptosis, glycolysis process, and other processes. These findings indicate that ENO1 is a potential prognostic biomarker that correlates with cancer progression immune infiltration.https://www.frontiersin.org/articles/10.3389/fonc.2020.593706/fullEnolase 1 (ENO1)biologic tumor markermutationtumor-infiltratingprognosis |
spellingShingle | Wenhua Xu Wenna Yang Chunfeng Wu Xiaocong Ma Haoyu Li Jinghui Zheng Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis Frontiers in Oncology Enolase 1 (ENO1) biologic tumor marker mutation tumor-infiltrating prognosis |
title | Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis |
title_full | Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis |
title_fullStr | Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis |
title_full_unstemmed | Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis |
title_short | Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis |
title_sort | enolase 1 correlated with cancer progression and immune infiltrating in multiple cancer types a pan cancer analysis |
topic | Enolase 1 (ENO1) biologic tumor marker mutation tumor-infiltrating prognosis |
url | https://www.frontiersin.org/articles/10.3389/fonc.2020.593706/full |
work_keys_str_mv | AT wenhuaxu enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis AT wennayang enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis AT chunfengwu enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis AT xiaocongma enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis AT haoyuli enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis AT jinghuizheng enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis |